# Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine

> **NCT00952757** · — · COMPLETED · sponsor: **Investigaciones Médicas Montejo S.L.** · enrollment: 35 (actual)

## Conditions studied

- APS-related Hyperprolactinaemia
- Schizophrenia
- Bipolar Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00952757
- **Lead sponsor:** Investigaciones Médicas Montejo S.L.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2009-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952757, "Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00952757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*